ヘルスケアにおけるエージェント型AIの基盤構築Building the foundation for agentic AI in healthcare

Microsoft has published a blog post outlining its approach to building the foundational infrastructure required for agentic AI in healthcare, a category of software designed to let autonomous AI agents take on parts of clinical and operational work. The topic matters because health systems face persistent staffing shortages, heavy administrative burdens, and growing data complexity, and technology vendors are increasingly positioning agent-based tools as a way to relieve some of that load while keeping clinicians in control of decisions.

Agentic AI refers to systems that go beyond single-turn question and answer exchanges. Rather than simply responding to a prompt, an agent can plan a sequence of steps, call external tools or data sources, and carry out multi-stage tasks with limited human intervention. In a medical context, that could mean an agent that gathers information from several systems, drafts documentation, surfaces follow-up actions, or coordinates routine administrative processes such as scheduling and prior authorization. Microsoft's framing emphasizes the word "foundation," pointing to the platform, data, and governance layers that appear to be prerequisites before such agents can operate safely and at scale.

A central challenge the company highlights is that healthcare data is fragmented across electronic health records, imaging systems, lab platforms, and billing software. For agents to be useful, they need reliable access to this information in a structured, standardized form. That is why interoperability standards such as FHIR (Fast Healthcare Interoperability Resources), and data platforms that can unify clinical and operational records, are typically described as core building blocks. Without a consistent data layer, an agent's outputs are likely to be incomplete or inconsistent, which carries real risk in a clinical environment.

Security, identity, and compliance form another pillar of the foundation. Autonomous agents that can read patient data and trigger actions raise questions about access control, auditability, and accountability. Healthcare organizations operate under strict regulatory regimes, including privacy rules such as HIPAA in the United States, so any deployment has to demonstrate that agents act within defined permissions and that their behavior can be traced and reviewed. Microsoft's emphasis on governance suggests it is trying to address these concerns as part of the platform rather than leaving them to individual customers.

The move builds on Microsoft's broader healthcare portfolio. The company has invested heavily in the sector, including its acquisition of Nuance and the ambient clinical documentation technology marketed under the Dragon and DAX branding, which listens to patient visits and drafts notes for clinician review. It also offers Azure-based AI services, a healthcare-focused data platform within Microsoft Fabric, and tooling such as Copilot Studio and Azure AI Foundry that organizations can use to build and orchestrate agents. Agentic AI can be seen as an extension of these efforts, shifting from tools that assist with a single task toward systems that can coordinate several tasks across a workflow.

The initiative also sits within a competitive industry landscape. Other major providers are pursuing similar directions, including Google with its medical-focused models and Amazon with clinical documentation services, while EHR vendors such as Epic are embedding AI features directly into their systems. This suggests that the underlying infrastructure question, how to connect models, data, and safeguards reliably, is becoming as important as the models themselves. Vendors that can offer a trusted, compliant foundation may be better positioned as healthcare organizations move from pilots to production use.

Important caveats remain. Autonomous agents in medicine will likely require rigorous clinical validation, ongoing monitoring, and clear human oversight, particularly where outputs could influence care. Large language models can still produce inaccurate or fabricated information, a risk that is especially serious in clinical settings, so keeping a person in the loop and constraining what agents are permitted to do independently appear central to responsible deployment. Regulatory expectations around AI in medical devices and clinical decision support are also still evolving.

For healthcare leaders, the practical takeaway is that adopting agentic AI is not simply a matter of turning on a new feature. It depends on getting the groundwork right: unified and interoperable data, robust security and identity controls, governance and audit capabilities, and integration with existing clinical systems. Microsoft's post positions the company as focused on that groundwork, framing the foundation as the necessary step before autonomous agents can meaningfully support clinical and operational workflows.